Arcturus Therapeutics to Attend the Following Investor Conferences

SAN DIEGO–(BUSINESS WIRE)–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences. Citi’s 17th Annual BioPharma Conference (Attending) Tuesday – Thursday, September 6 – 8, 2022 Wells Fargo Virtual Heal
Click here to view original post